BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22952619)

  • 21. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
    Augoff K; McCue B; Plow EF; Sossey-Alaoui K
    Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression.
    Sossey-Alaoui K; Ranalli TA; Li X; Bakin AV; Cowell JK
    Exp Cell Res; 2005 Aug; 308(1):135-45. PubMed ID: 15907837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.
    Gärtner S; Gunesch A; Knyazeva T; Wolf P; Högel B; Eiermann W; Ullrich A; Knyazev P; Ataseven B
    PLoS One; 2014; 9(1):e84472. PubMed ID: 24409301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
    Jin H; Xie Q; Guo X; Xu J; Wang A; Li J; Zhu J; Wu XR; Huang H; Huang C
    J Biol Chem; 2017 Sep; 292(38):15952-15963. PubMed ID: 28794159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.
    Hamester F; Stürken C; Saygi C; Qi M; Legler K; Gorzelanny C; Robador JR; Schmalfeldt B; Laakmann E; Müller V; Witzel I; Oliveira-Ferrer L
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR5/7-mediated PI3K activation triggers epithelial-mesenchymal transition of ovarian cancer cells through WAVE3-dependent mesothelin or OCT4/SOX2 expression.
    Park GB; Kim D
    Oncol Rep; 2017 Nov; 38(5):3167-3176. PubMed ID: 28901470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association Between WAVE1 and -3 and the ARP2/3 Complex in PC 3 Cells.
    Weeks HP; Sanders AJ; Kynaston HG; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1135-42. PubMed ID: 26977009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Abl-mediated phosphorylation of WAVE3 is required for lamellipodia formation and cell migration.
    Sossey-Alaoui K; Li X; Cowell JK
    J Biol Chem; 2007 Sep; 282(36):26257-65. PubMed ID: 17623672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer.
    Huang S; Huang C; Chen W; Liu Y; Yin X; Lai J; Liang L; Wang Q; Wang A; Zheng C
    Int J Oncol; 2018 Aug; 53(2):672-684. PubMed ID: 29845225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
    Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
    Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
    Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
    Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
    Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
    PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.
    Cui YX; Bradbury R; Flamini V; Wu B; Jordan N; Jiang WG
    Br J Cancer; 2017 Jun; 117(1):89-101. PubMed ID: 28571043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis.
    Sossey-Alaoui K
    Semin Cell Dev Biol; 2013 Apr; 24(4):287-97. PubMed ID: 23116924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WAVE3 phosphorylation regulates the interplay between PI3K, TGF-β, and EGF signaling pathways in breast cancer.
    Wang W; Kansakar U; Markovic V; Wang B; Sossey-Alaoui K
    Oncogenesis; 2020 Oct; 9(10):87. PubMed ID: 33012785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
    Kuo WH; Chang YY; Lai LC; Tsai MH; Hsiao CK; Chang KJ; Chuang EY
    PLoS One; 2012; 7(9):e45831. PubMed ID: 23049873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer.
    Maris P; Blomme A; Palacios AP; Costanza B; Bellahcène A; Bianchi E; Gofflot S; Drion P; Trombino GE; Di Valentin E; Cusumano PG; Maweja S; Jerusalem G; Delvenne P; Lifrange E; Castronovo V; Turtoi A
    PLoS Med; 2015 Sep; 12(9):e1001871. PubMed ID: 26327350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.